Goa Vibrant Summit -2026 to offer African nations investment opportunities in pharma, medtech and other manufacturing sectors ...
US FDA approves Instylla’s Embrace Hydrogel Embolic System for peripheral arterial bleeds: Burlington, Massachusetts Saturday, October 31, 2026, 18:00 Hrs [IST] Instylla, Inc., ...
Clinical research, low-cost innovation to make India global leader in regenerative medicine: Dr Sharmila Tulpule: Shardul Nautiyal, Mumbai Saturday, October 31, 2026, 08:00 Hrs [I ...
SKCDA urges FSDA to investigate irregularities in drug procurement & disposal in govt medical college hospitals: Nandita Vijayasimha, Bengaluru Saturday, October 31, 2026, 08:00 H ...
DDS enhances efficacy & safety of drug via controlling rate, timing & location of drug release: Komal Saini: Yash Ved, Mumbai Saturday, October 31, 2026, 08:00 Hrs [IST] The drug ...
Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation: Shashank Deshpande: Seoul, Korea Saturday, October 31, 2026, 13:00 Hrs [IST] Boehri ...
IDMA’s Silver Jubilee Pharmaceutical Analysts’ Convention to focus on AI, digitalisation and future-ready quality systems: Shardul Nautiyal, Mumbai Saturday, October 31, 2026, ...
TMR's one-time margin cut fails to keep prices of anti-cancer drugs under effective control, says AIDAN: Our Bureau, New Delhi Saturday, October 31, 2026, 13:45 Hrs [IST] The mark ...
India must harness the knowledge & expertise of registered pharmacists beyond dispensing: AIPDA: Nandita Vijayasimha, Bengaluru Saturday, October 31, 2026, 08:00 Hrs [IST] The All ...
NABL releases application form for quality recognition of NACO-linked HIV and syphilis testing laboratories: Shardul Nautiyal, Mumbai Saturday, October 31, 2026, 08:00 Hrs [IST] T ...
Alkermes plc, a global biopharmaceutical company, announced the initiation of a phase 2 study evaluating the safety and efficacy of ALKS 7290 as an adjunctive therapy to antidepressants in adult ...
Pretzel Therapeutics receives UK MHRA authorization to advance PX578 into clinical development in patients to treat POLG-mediated primary mitochondrial disorders: Waltham, Massach ...